Important safety considerations include a boxed warning for medullary thyroid carcinoma risk (contraindicated in patients with personal/family history of MTC or Multiple Endocrine Neoplasia syndrome type 2), and warnings regarding pancreatitis, gallbladder disease, and hypoglycemia risk when used with insulin or sulfonylureas
Continued Monitoring: Regular follow-ups with your healthcare provider to assess tolerance and progress
Very friendly and knowledgeable staff
April 8, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
Wegovy is a pioneering semaglutide injection used once a week, while the oral Wegovy pill is available for those who prefer not to take injections